David Ball
Overview
Explore the profile of David Ball including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
189
Citations
3674
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Singh H, Sharma V, Nijssen J, Pozniakovski A, Rubin A, Liang L, et al.
bioRxiv
. 2025 Mar;
PMID: 40034645
The mesoscale organization of cells is central to cellular physiology and pathology. Cellular condensates often form via biomolecular phase separation, mediated by intrinsically disordered regions (IDRs) and represent a key...
2.
Kapadia A, Greear G, Chen T, Ball D, McClure R, Ostrowski K, et al.
Transl Androl Urol
. 2025 Jan;
13(12):2672-2680.
PMID: 39816230
Background: Sperm extraction by Microscopic Testicular Sperm Extraction (microTESE) has become the standard of care for sperm retrieval (SR) in men with non-obstructive azoospermia (NOA) but is costly and has...
3.
Kiss N, Prado C, Abbott G, Edbrooke L, Denehy L, Curtis A, et al.
Eur J Clin Nutr
. 2024 Nov;
PMID: 39614103
Background: This study examined (1) associations between sociodemographic and clinical variables with low muscle mass and radiodensity and their loss relative to treatment commencement in patients with lung cancer; and...
4.
Byrne A, De Abreu Lourenco R, Govindaraj R, Ball D, Le H
J Med Imaging Radiat Oncol
. 2024 Oct;
68(7):843-850.
PMID: 39382099
Introduction: Stereotactic ablative radiotherapy (SABR) is a standard of care treatment for medically inoperable early-stage non-small-cell lung cancer (NSCLC). The CHISEL trial was a phase 3 randomised controlled trial that...
5.
Kiss N, Ugalde A, Prado C, Denehy L, Daly R, Siva S, et al.
PLoS One
. 2024 Jul;
19(7):e0304003.
PMID: 39074132
Objectives: To 1) explore the experience of patients with lung cancer with low muscle mass or muscle loss during treatment and the ability to cope with treatment, complete self-care, and...
6.
Bucknell N, Hardcastle N, Mcintosh L, Ball D, Hofman M, Kron T, et al.
Pract Radiat Oncol
. 2024 May;
14(6):e480-e486.
PMID: 38705233
Purpose: Functional lung avoidance (FLA) radiation therapy is an evolving field. The aim of FLA planning is to reduce dose to areas of functioning lung, with comparable target coverage and...
7.
Buerger F, Salmanullah D, Liang L, Gauntner V, Krueger K, Qi M, et al.
medRxiv
. 2024 Apr;
PMID: 38562757
In genetic disease, an accurate expression landscape of disease genes and faithful animal models will enable precise genetic diagnoses and therapeutic discoveries, respectively. We previously discovered that variants in ,...
8.
Wallace N, Alexander M, Xie J, Ball D, Hegi-Johnson F, Plumridge N, et al.
Lung Cancer
. 2024 Mar;
190:107531.
PMID: 38513538
Introduction: Smoking is a risk factor for the development of lung cancer and reduces life expectancy within the general population. Retrospective studies suggest that non-smokers have better outcomes after treatment...
9.
Aryee A, Rockenschaub P, Robson J, Ahmed Z, Nic Fhogartaigh C, Ball D, et al.
J Antimicrob Chemother
. 2023 Nov;
79(1):134-142.
PMID: 37974396
Objectives: To investigate the risk of adverse outcomes following discordant antibiotic treatment (urinary organism resistant) for culture-confirmed community-onset lower urinary tract infection (UTI). Methods: Cohort study using routinely collected linked...
10.
Bucknell N, Hardcastle N, Bressel M, Moore A, Montgomery R, Murnane A, et al.
Int J Radiat Oncol Biol Phys
. 2023 Oct;
118(4):944-951.
PMID: 37871885
Purpose: The TROG 13.01 (SAFRON II) trial was a phase 2 multicenter trial comparing single-fraction (SF) and multifraction (MF) stereotactic body radiation therapy. Patients with 1 to 3 peripheral pulmonary...